PuraPharm Corporation Limited (HKG:1498)

PuraPharm Corporation Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	190	217	356	506	319	267
Market Cap Growth	-38.89%	-38.89%	-29.69%	58.47%	19.41%	-20.03%
Enterprise Value	516	579	734	886	732	583
Last Close Price	0.48	0.55	0.90	1.28	0.81	0.68
PE Ratio	-	-	-	-	-	8.43
Forward PE	-	13.33	13.33	13.33	13.33	12.95
PS Ratio	0.50	0.57	0.87	1.13	0.48	0.44
PB Ratio	1.71	1.95	2.32	1.96	0.80	0.52
P/TBV Ratio	3.07	3.52	3.54	2.53	0.94	0.70
P/FCF Ratio	2.13	2.44	5.88	7.47	-	6.10
P/OCF Ratio	1.82	2.09	4.47	5.71	-	2.23
EV/Sales Ratio	1.35	1.52	1.80	1.98	1.11	0.97
EV/EBITDA Ratio	15.50	39.56	-	-	18.24	-
EV/EBIT Ratio	-	-	-	-	48.34	-
EV/FCF Ratio	5.79	6.49	12.14	13.10	-	13.32
Debt / Equity Ratio	3.27	3.27	2.77	1.95	1.33	1.02
Debt / EBITDA Ratio	10.82	10.82	-	-	8.53	24.20
Debt / FCF Ratio	4.08	4.08	7.03	7.44	-	11.96
Asset Turnover	0.49	0.49	0.44	0.40	0.51	0.46
Inventory Turnover	1.18	1.18	1.04	0.95	1.21	1.16
Quick Ratio	0.20	0.20	0.23	0.35	0.54	0.60
Current Ratio	0.55	0.55	0.61	0.73	0.92	1.03
Return on Equity (ROE)	-26.80%	-26.80%	-51.55%	-36.44%	-26.69%	7.26%
Return on Assets (ROA)	-1.51%	-1.51%	-3.57%	-3.84%	0.73%	-1.15%
Return on Capital (ROIC)	-2.24%	-2.24%	-4.96%	-5.03%	0.96%	-1.54%
Return on Capital Employed (ROCE)	-	-	-	-	2.80%	-
Earnings Yield	-18.69%	-16.31%	-29.84%	-23.77%	-38.20%	11.87%
FCF Yield	47.03%	41.04%	16.99%	13.38%	-5.52%	16.39%
Buyback Yield / Dilution	-	-	-0.12%	-0.22%	-6.01%	-42.44%
Total Shareholder Return	-	-	-0.12%	-0.22%	-6.01%	-42.44%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.